Sofokast Plus

Daclatasvir and Sofosbuvir Tablets 60 mg/400 mg

Email Directly

WHO-GMP Certified

Global Export Ready

Quality Assured

Enquire NOW!

Medicine*

Your Name*

Your Email*

Your Phone*

Your Country*

Message

Categories: Hepatitis C Medicine Manufacturer, Hepatology

Description

Description

COMPOSITION: Each tablet contains Sofosbuvir 400 mg + Daclatasvir 60 mg

INDICATION: SOFOKAST PLUS is a fixed dose combination of hepatitis c virus nucleotide analog NSSB polymerase inhibitor and NSSA inhibitor indicated for the treatment of:

Adult patients with genotype 1, 2, 3 or 4 chronic HcV infection without cirrhosis or with c0mpensated cirrhosis pax of c0mbination antiviral treatment regimen.

PACKING: 28 Tablets / Bottle

Disclaimer: This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence-based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Any liability for patent infringement is at the buyer's risk. The website does not sell/purchase any medicine.

Sofokast Plus

Thank you for your enquiry. We will get back to you shortly!